XERS, CARL Stocks Hit All-Time Highs Today – Here’s What Analysts Are Saying
Analysts raised price targets on Xeris and Carlsmed after the companies reported better-than-expected third-quarter revenue and raised their fiscal 2026 guidance
Analysts raised price targets on Xeris and Carlsmed after the companies reported better-than-expected third-quarter revenue and raised their fiscal 2026 guidance